文献速递外周动脉疾病

外周血管介入术后对比剂肾病:长期肾脏结局及进行性肾功能不全的危险因素

Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
PubMed 文献 · J Vasc Surg · 2018-10-03

该研究纳入2008至2015年在本机构接受外周血管介入(PVI)且符合标准的881例患者,其中57例(6.5%)发生对比剂肾病(CIN)。多因素分析显示男性(P=.027)和充血性心力衰竭(P=.048)与1年GFR下降相关,30天肌酐升高百分比亦相关(P=.025),而出院时CIN缓解(平均13.1天)对1年肾功能有保护作用(P=.02)。

要点

  • 881例PVI患者中57例(6.5%)发生CIN,53%在出院时缓解。
  • 男性(P=.027)和充血性心力衰竭(P=.048)与1年GFR下降相关。
  • 出院时CIN持续者1年肾功能恶化程度大于非CIN患者(P=.016)。

核心结论

  • 男性和充血性心力衰竭是PVI后发生CIN患者肾功能进一步下降的危险因素。
  • 肌酐升高的幅度和持续时间(出院时CIN持续)与CIN患者晚期进行性肾功能不全相关,提示早期缓解的CIN相对良性。

研究设计与样本

  • 回顾性查询2008至2015年在本机构(属全州血管介入协作组)接受PVI的患者。
  • CIN定义为介入后30天内血清肌酐浓度升高至少0.5 mg/dL。
  • 排除术前透析或术后无肌酐值的患者,最终881例符合纳入标准。

主要发现

  • 881例中57例(6.5%)发生CIN,其中47%为男性,51%有基线慢性肾脏病。
  • 30例(53%)在出院时CIN缓解。
  • 多因素线性回归显示男性(P=.027)和充血性心力衰竭(P=.048)与1年GFR下降相关。
  • 30天术后肌酐升高百分比与1年GFR下降相关(P=.025),出院时CIN缓解(平均13.1天)对1年肾功能有保护作用(P=.02)。
  • 事后分析随机选取50例未发生CIN的PVI患者,出院时CIN缓解者1年肾脏结局与非CIN患者相似,而出院时CIN持续者1年肾功能恶化程度大于非CIN患者(P=.016)。

关键数值与推荐

  • CIN定义:介入后30天内血清肌酐浓度升高至少0.5 mg/dL。
  • ΔGFR定义为术前GFR减去1年GFR。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Contrast-induced nephropathy (CIN) is a frequently used quality outcome marker after peripheral vascular interventions (PVIs). Whereas the factors associated with CIN development have been well documented, the long-term renal effects of CIN after PVI are unknown. This study was undertaken to investigate the long-term (1-year) renal consequences of CIN after PVI and to identify factors associated with renal function deterioration at 1-year follow-up. METHODS: From 2008 to 2015, patients who had PVI at our institution (who were part of a statewide Vascular Interventions Collaborative) were queried for those who developed CIN. CIN was defined by the Collaborative as an increase in serum creatinine concentration of at least 0.5 mg/dL within 30 days after intervention. Preprocedural dialysis patients or patients without postprocedural creatinine values were excluded. Preprocedural, postprocedural, and 1-year serum creatinine values were abstracted and used to estimate glomerular filtration rate (GFR). ΔGFR was defined as preprocedural GFR minus 1-year GFR. Univariate and multivariate analyses for ΔGFR were performed to determine factors associated with renal deterioration at 1 year. RESULTS: From 2008 to 2015, there were 1323 PVIs performed; 881 patients met the inclusion criteria. Of these, 57 (6.5%) developed CIN; 47% were male, and 51% had baseline chronic kidney disease. CIN resolved by discharge in 30 patients (53%). Using multivariate linear regression, male sex (P = .027) and congestive heart failure (P = .048) were associated with 1-year GFR decline. Periprocedural variables related to 1-year GFR decline included percentage increase in 30-day postprocedural creatinine concentration (P = .025), whereas CIN resolution by discharge (mean, 13.1 days) was protective for renal function at 1 year (P = .02). A post hoc analysis was performed with 50 PVI patients (randomly selected) who did not develop CIN, comparing their late renal function with that of the CIN group stratified by the periprocedural 30-day variables. Patients with CIN resolution at discharge had similar 1-year renal outcomes to non-CIN patients, whereas the CIN-persistent (at discharge) patients had greater renal deterioration at 1 year compared with non-CIN patients (P = .016). CONCLUSIONS: Male sex and congestive heart failure are risk factors for further renal function decline in patients developing CIN after PVI. The magnitude and duration of increase in creatinine concentration (CIN persistence at discharge) correlated with late progressive renal dysfunction in CIN patients, suggesting that early-resolving CIN is relatively benign.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Al Adas Z, Lodewyk K, Robinson D, et al. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction. J Vasc Surg. 2018. PMID: 30292616. doi:10.1016/j.jvs.2018.06.196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。